journal article·2025-03Open access

Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification

Zhenyang Wei, Mingyu Zhu, Nicolas Morin, Daniela Wollsten, Jouni Hirvonen, Xiangliang Yang, Hélder A. Santos, Wei Li

Advanced Functional Materials· Volume 35· Issue 11

Abstract

Abstract High drug‐loaded polymeric microspheres hold promise in biomedical fields due to reduced excipient administration, minimized side effects, and enhanced therapeutical efficacy. Although thermodynamic factors like drug‐carrier material compatibility are well‐known to influence the drug loading capacity of microspheres, they fail to explain the huge difference in drug loading degree observed for polymers and drugs with similar interactions. Here, based on the droplet microfluidic platform, the single droplet solidification process is investigated. The results indicated that amorphous polymers can hinder drug diffusion during droplet solidification compared to crystalline polymers, resulting in a higher drug loading degree. Next, this principle is applied to improve the drug loading capability of crystalline polymers (polycaprolactone (PCL) and poly(L‐lactide) (PLLA)) by random co‐polymerization (poly(caprolactone‐co‐L‐lactide) (PCL‐PLLA)), achieving 6.2–22.2 times increased drug loading degree. Moreover, PCL‐PLLA microspheres with a high content of indomethacin exhibited superior therapeutical efficacy in the treatment of gout arthritis. Overall, these results offer insights into the impact of polymer crystallization on droplet solidification kinetics, which consequently affects the drug loading capacity. These findings provide guidelines for the development of polymers for efficient drug encapsulation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Innovative Microfluidic and Catalytic Techniques Innovation · 3D Printing in Biomedical Research · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Engineering Research Center for Nanomedicine College of Life Science and Technology Huazhong University of Science and Technology Wuhan 430074 China

Drug Research Program Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki 00014 Finland

Department of Biomaterials and Biomedical Technology The Personalized Medicine Research Institute (PRECISION) University Medical Center Groningen (UMCG) University of Groningen Ant. Deusinglaan 1 Groningen 9713 AV The Netherlands

Funding

Research Council of Finland

References (68)

Show source-provided references
1. 10.1039/B801739P10.1039/B801739P ↗
2. 10.1126/science.aaf744710.1126/science.aaf7447 ↗
3. 10.1126/scitranslmed.aaz660610.1126/scitranslmed.aaz6606 ↗
4. 10.1016/j.cell.2015.04.04410.1016/j.cell.2015.04.044 ↗
5. 10.1126/science.106759510.1126/science.1067595 ↗
6. 10.1038/nrd436310.1038/nrd4363 ↗
7. 10.1038/s41467-022-28787-710.1038/s41467-022-28787-7 ↗
8. 10.1021/jacs.5b0997410.1021/jacs.5b09974 ↗
9. 10.1016/j.xphs.2016.05.02910.1016/j.xphs.2016.05.029 ↗
10. 10.1038/s41467-018-03691-110.1038/s41467-018-03691-1 ↗
11. 10.1038/s41593-020-00789-y10.1038/s41593-020-00789-y ↗
12. 10.1016/j.addr.2015.04.00810.1016/j.addr.2015.04.008 ↗
13. 10.1016/j.jconrel.2004.10.01510.1016/j.jconrel.2004.10.015 ↗
14. 10.1021/jacs.7b1277610.1021/jacs.7b12776 ↗
15. 10.1038/ncomms1122110.1038/ncomms11221 ↗
16. 10.1002/jps.1053310.1002/jps.10533 ↗
17. 10.1021/acs.biomac.8b0021810.1021/acs.biomac.8b00218 ↗
18. 10.1016/S0169-409X(97)00049-510.1016/S0169-409X(97)00049-5 ↗
19. 10.1016/j.ijpharm.2008.04.04210.1016/j.ijpharm.2008.04.042 ↗
20. 10.1016/j.ijpharm.2004.04.01310.1016/j.ijpharm.2004.04.013 ↗
21. 10.1002/smll.20190467310.1002/smll.201904673 ↗
22. 10.1021/acs.chemrev.6b0084810.1021/acs.chemrev.6b00848 ↗
23. 10.1016/j.actbio.2021.10.03710.1016/j.actbio.2021.10.037 ↗
24. 10.1038/s43586-023-00212-310.1038/s43586-023-00212-3 ↗
25. 10.1039/C7LC00242D10.1039/C7LC00242D ↗
26. 10.1016/j.jddst.2016.01.01010.1016/j.jddst.2016.01.010 ↗
27. 10.1038/s41584-018-0149-710.1038/s41584-018-0149-7 ↗
28. 10.1038/s41572-019-0115-y10.1038/s41572-019-0115-y ↗
29. 10.1039/C9TB01795J10.1039/C9TB01795J ↗
30. 10.1034/j.1399-6576.2000.440607.x10.1034/j.1399-6576.2000.440607.x ↗
31. 10.1038/254308a010.1038/254308a0 ↗
32. 10.1038/s41467-020-19232-810.1038/s41467-020-19232-8 ↗
33. 10.1038/s41467-024-47640-710.1038/s41467-024-47640-7 ↗
34. 10.1186/s12974-021-02131-010.1186/s12974-021-02131-0 ↗
35. 10.1038/nature0166110.1038/nature01661 ↗
36. 10.1002/adma.20230412310.1002/adma.202304123 ↗
37. 10.1021/acs.nanolett.3c0419610.1021/acs.nanolett.3c04196 ↗
38. 10.1038/nrrheum.2009.23610.1038/nrrheum.2009.236 ↗
39. 10.1002/art.2418510.1002/art.24185 ↗
40. 10.1016/j.bioactmat.2021.06.00310.1016/j.bioactmat.2021.06.003 ↗
41. 10.1016/j.jconrel.2017.01.04710.1016/j.jconrel.2017.01.047 ↗
42. 10.1038/s41467-021-25856-110.1038/s41467-021-25856-1 ↗
43. 10.1016/j.addr.2020.09.00910.1016/j.addr.2020.09.009 ↗
44. 10.1021/acsnano.5b0092910.1021/acsnano.5b00929 ↗
45. 10.1002/anie.20080049110.1002/anie.200800491 ↗
46. 10.1038/nrd246810.1038/nrd2468 ↗
47. 10.1002/adma.20180115910.1002/adma.201801159 ↗
48. 10.3109/0265204870902182110.3109/02652048709021821 ↗
49. 10.1081/DDC-4398510.1081/DDC-43985 ↗
50. 10.1080/0265204040001538710.1080/02652040400015387 ↗
51. 10.1016/j.ijpharm.2005.06.02910.1016/j.ijpharm.2005.06.029 ↗
52. 10.1021/acs.biomac.5b0082610.1021/acs.biomac.5b00826 ↗
53. 10.1021/bm401312j10.1021/bm401312j ↗
54. 10.1016/j.colsurfb.2018.08.03710.1016/j.colsurfb.2018.08.037 ↗
55. 10.1016/S0378-5173(00)00574-310.1016/S0378-5173(00)00574-3 ↗
56. 10.1038/ncomms1123510.1038/ncomms11235 ↗
57. 10.1038/nbt0798-65210.1038/nbt0798-652 ↗
58. 10.1002/adhm.20220084610.1002/adhm.202200846 ↗
59. 10.1016/j.addr.2013.05.00910.1016/j.addr.2013.05.009 ↗
60. 10.1016/j.semarthrit.2020.04.01010.1016/j.semarthrit.2020.04.010 ↗
61. 10.1097/BOR.000000000000058310.1097/BOR.0000000000000583 ↗
62. 10.1111/jcpt.1366910.1111/jcpt.13669 ↗
63. Leow M. Q. H. · Cochrane Db. Syst. Rev. · 2021 · 4
64. 10.1016/j.jconrel.2016.11.00310.1016/j.jconrel.2016.11.003 ↗
65. 10.1016/j.biomaterials.2014.10.07910.1016/j.biomaterials.2014.10.079 ↗
66. 10.1063/1.173773910.1063/1.1737739 ↗
67. 10.1126/science.110916410.1126/science.1109164 ↗
68. 10.1002/advs.20230832510.1002/advs.202308325 ↗